Staar CE-marks SonicWAVE phacoemulsification system:
This article was originally published in Clinica
Staar Surgical has CE-marked for sale in Europe its SonicWAVE phacoemulsification system for removing a cataract lens from the eye. This is achieved by using low frequency (40-400Hz) sonic pulses, a process which avoids the generation of heat and reduces the risk of corneal burns. This is an area on which the industry has focused increasingly over recent years, says the Monrovia, California firm. Staar, which plans to begin shipping the product this month, estimates that the European market for cataract removal equipment and accessories is worth around $300 million.
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.